- Country: Ukraine
- Summary: Pyridoxine (Vitamin B6), Solution for Injection, 50 Mg/Ml, 1 Ml Each; L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Citicoline, Solution for Injection, 250 Mg/Ml, 4 Ml Each; Thiamine Chloride (Vitamin B1...
- UAT Ref No: 130530760
- Deadline: 22 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 193000
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-19-003318-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Pyridoxine (vitamin B6), solution for injection, 50 mg/ml, 1 ml each; L-lysine escinate, solution for injection, 1 mg/ml, 5 ml each; Citicoline, solution for injection, 250 mg/ml, 4 ml each; Thiamine chloride (vitamin B1), solution for injection, 50 mg/ml, 1 ml each; Nicotinic acid solution for injection 10 mg/ml in 1 ml; Dexketoprofen solution for injection 25 mg/ml in 2 ml; Spasmolytic agents in combination with analgesic tablets; Piracetam, solution for injection, 200 mg/ml, 5 ml each
Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Technical and qualitative characteristics, in compliance with the Law on Medicinal Products and Resolution of the CMU No. 376 dated 26.05.2005 (as amended), when signing this contract are confirmed by scanned copies of registration certificates provided by the SUPPLIER for the product, the quantity of which is and exceeds 100 units of measurement in the secondary packaging, which must be certified by the signature and seal of the manufacturer (if it is used), or the applicant, or an authorized representative, dealer or distributor (with appropriate confirmation of their authority in the form of powers of attorney or letters of authorization of manufacturers for representation/distribution), with an indication of the date of certification, which will be higher... More Name Classifier and its corresponding code Quantity/Unit of measurement Place of delivery Date of delivery Name
DK 021:2015: 33600000-6 — Pharmaceutical products Technical and quality characteristics, in compliance with the Law on medicinal products and Resolution of the CMU No. 376 of 26.05.2005 (with amendments), when signing this contract, are confirmed by scanned copies of registration certificates provided by the SUPPLIER for the product, the quantity of which is and exceeds 100 units of measurement in secondary packaging, which must be certified by the manufacturer's signature and seal (in the case... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPyridoxine (Vitamin B6), Solution for Injection, 50 Mg/Ml, 1 Ml Each; L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Citicoline, Solution for Injection, 250 Mg/Ml, 4 Ml Each; Thiamine Chloride (Vitamin B1... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "CITY CLINICAL HOSPITAL NO. 27" OF THE KHARKIV CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Pyridoxine (Vitamin B6), Solution for Injection, 50 Mg/Ml, 1 Ml Each; L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Citicoline, Solution for Injection, 250 Mg/Ml, 4 Ml Each; Thiamine Chloride (Vitamin B1.... This tender is published on UkraineTenders under UAT Ref No: 130530760 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-22.
The estimated tender value is UAH 193000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
